Notification on Revision of Consolidated Earnings Forecast
In light of recent trends in our business performance, we have revised the full-year of the fiscal year ending February 29,2024, announced on December 26,2023.
● Revision of Consolidated Earnings Forecast for the Fiscal Year Ending February 29, 2024
(March 1, 2023 to February 29, 2024)
Net sales
Operating profit
Ordinary profit
Profit attributable to owners of parent
Earnings Per
Share
Previous forecast (A)
million yen 742,500
million yen 35,000
million yen 36,500
million yen 20,500
Yen 339.87
Revised forecast (B)
742,500
36,500
37,500
21,500
356.44
Changed Amount (B-A)
0
1,500
1,000
1,000
Changed Ratio (%)
0
4.3
2.7
4.9
(Reference) Previous results
(FY ended February 28, 2023)
667,647
31,658
32,391
19,007
Yen 311.45
● Reasons for the revision
In the third quarter results (December 26, 2023), the Company upwardly revised its full-year forecast, mainly due to an increase in demand for cosmetics as a result of the easing of behavioral restrictions and a gradual recovery in inbound demand, and sales continue to be strong and profitability has further improved.
Since operating income, ordinary income, and net income attributable to owners of the parent are all expected to exceed the previously announced forecasts, the full-year consolidated forecasts have been revised upward again.
*The above earnings forecasts are based on current available information. Actual results may differ from forecasted figures above due to various factors.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Sugi Holdings Co. Ltd. published this content on
26 March 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
26 March 2024 06:39:07 UTC.
SUGI HOLDINGS CO.,LTD. is a Japan-based holding company mainly engaged in management of the drug stores and dispensing business. Through its subsidiaries, the Company is engaged in the sale of medicines, health foods, cosmetics, daily necessities and prescription preparations, as well as the operation of local healthcare compliant drug store that tackles home healthcare in cooperation with regional medical personnel. The Company also operates visiting nursing stations that closely cooperate with regional medical institutions and social welfare operators, through the provision of visiting nursing services and in-home nursing care support services.